Tommy Tanzer, a resident of Park City, Utah, received three negative prostate biopsies over the course of three years, but he and his doctors still suspected he may have cancer. Tommy then had an MRI-guided biopsy at Huntsman Cancer Institute (HCI), hoping there would be a more accurate result. Unfortunately, this biopsy did detect cancer. Fortunately, it was found early enough to treat.
Huntsman Cancer Institute (HCI) is pleased to announce the appointment of two of our colleagues as holders of prestigious endowed chairs at the University of Utah. Endowed chairs recognize academic distinction, promote excellence, and provide funds for cutting-edge research.
Jonathan Tward, MD, PhD, explains how he began his career as a radiation oncologist, what he's learned from his patients, and why he loves an unusual sport.
​Choosing the right treatment after being diagnosed with prostate cancer can seem overwhelming. Here are some things to consider as you work with your doctor to choose the best option.
Huntsman Cancer Institute (HCI) researcher Andrew Hahn, MD, received an award for his work in genitourinary cancers from the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO). The Conquer Cancer Foundation of ASCO Merit Award recognizes young researchers who have made a significant impact to their field of study and promotes clinical cancer research by giving recipients the chance to present their findings at conferences.